RMR compared with KROS: revenue, margins and what each company keeps, and the suppliers and customers both name

RMRRMR Group Inc.

Mkt capRevenueRevenue

KROSKeros Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

RMRRMR Group Inc.

KROSKeros Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only RMR 13

SVCService Properties Trustcustomer

SEVNSeven Hills Realty Trustcustomer

—Sevnunlistedsupplier

—AlerisLifeunlistedcustomer

9 more · RMR chain ›

Shared 0

No shared counterparties.

Only KROS 4

TAKTakeda Pharmaceuticalcustomer

—The General Hospitalunlistedsupplier

—Hansoh (Shanghai) Healthtechunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Takeda Pharmaceuticals U.S.A

unlistedcustomer

RMRRMR Group Inc.

16.86▼−0.85%

Mkt cap$545.4MRevenue$154MQ3 FY26Revenue$704MFY25

KROSKeros Therapeutics, Inc.

10.92▲+1.47%

Regular sessionNov 3 '26

Mkt cap$213.3MRevenue$367,000Q1 FY26Revenue$244MFY25

Compare

Regular sessionNov 3 '26

RMRRMR Group Inc.

KROSKeros Therapeutics, Inc.

16.86▼−0.85%

Price

10.92▲+1.47%

$545.4M

Mkt cap

$213.3M

Q3 FY26$154M

Revenue

$367,000Q1 FY26

FY25$704M

Revenue

$244MFY25

RMR16.86▼−0.85%vsKROS10.92▲+1.47%Regular sessionNov 3 '26